Argan (AGX) Cash & Equivalents (2010 - 2026)

Argan has disclosed Cash & Equivalents across 17 years of filings, most recently posting $339.5 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $339.5 million, up 133.7% year-over-year; the trailing twelve-month figure through Jan 2026 was $339.5 million (up 133.7% YoY), and the FY2026 annual result was $339.5 million, up 133.7% from the prior year.
• Cash & Equivalents came in at $339.5 million for Q1 2026 at Argan, up from $306.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $350.5 million in Q1 2022 to a low of $136.1 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $192.3 million (2022), against an average of $209.0 million.
• Across the five-year window, Cash & Equivalents tumbled 68.25% in 2022 and soared 133.7% in 2026, its largest moves.
• Argan's Cash & Equivalents stood at $136.1 million in 2022, then surged by 36.38% to $185.6 million in 2023, then slipped by 5.51% to $175.3 million in 2024, then jumped by 74.68% to $306.3 million in 2025, then climbed by 10.84% to $339.5 million in 2026.
• The last three Cash & Equivalents figures came in at $339.5 million (Q1 2026), $306.3 million (Q4 2025), and $177.8 million (Q3 2025), per Business Quant data.